Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (170)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Liang, Y.-C.
Right arrow Articles by Lin, J.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liang, Y.-C.
Right arrow Articles by Lin, J.-K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 20, No. 10, 1945-1952, October 1999
© 1999 Oxford University Press


Molecular Epidemiology and Cancer Prevention

Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages

Yu-Chih Liang, Ying-Tang Huang1, Shu-Huei Tsai, Shoei-Yn Lin-Shiau2, Chieh-Fu Chen3 and Jen-Kun Lin4

Institute of Biochemistry, College of Medicine, National Taiwan University, No. 1, Section 1, Jen-Ai Road, Taipei,
1 Institute of Biological Chemistry, Academia Sinica, Nan-Kang, Taipei,
2 Institute of Toxicology, College of Medicine, National Taiwan University, Taipei, Taiwan and
3 National Research Institute of Chinese Medicine, Taipei, Taiwan, Republic of China

Prostaglandins biosynthesis and nitric oxide production have been implicated in the process of carcinogenesis and inflammation. In this study, we investigated the effect of various flavonoids and (–)-epigallocatechin-3-gallate on the activities of inducible cyclooxygenase (COX-2) and inducible nitric oxide synthase (iNOS) in lipopolysaccharide (LPS)-activated RAW 264.7 macrophages. Apigenin, genistein and kaempferol were markedly active inhibitors of transcriptional activation of COX-2, with IC50 < 15 µM. In addition, apigenin and kaempferol were also markedly active inhibitors of transcriptional activation of iNOS, with IC50 < 15 µM. Of those compounds tested, apigenin was the most potent inhibitor of transcriptional activation of both COX-2 and iNOS. Western and northern blot analyses demonstrated that apigenin significantly blocked protein and mRNA expression of COX-2 and iNOS in LPS-activated macrophages. Transient transfection experiments showed that LPS caused an ~4-fold increase in both COX-2 and iNOS promoter activities, these increments were suppressed by apigenin. Moreover, electrophoretic mobility shift assay (EMSA) experiments indicated that apigenin blocked the LPS-induced activation of nuclear factor-kB (NF-kB). The inhibition of NF-kB activation occurs through the prevention of inhibitor kB (IkB) degradation. Transient transfection experiments also showed that apigenin inhibited NF-kB-dependent transcriptional activity. Finally, we showed that apigenin could inhibit the IkB kinase activity induced by LPS or interferon-{gamma}. The results of further studies suggest that suppression of transcriptional activation of COX-2 and iNOS by apigenin might mainly be mediated through inhibition of IkB kinase activity. This study suggests that modulation of COX-2 and iNOS by apigenin and related flavonoids may be important in the prevention of carcinogenesis and inflammation.

Abbreviations: COX, cyclooxygenase; EGF, epidermal growth factor; EGCG, (–)-epigallocatechin-3-gallate; EIA, enzyme immunoassay; EMSA, electrophoretic mobility shift assay; iNOS, inducible nitric oxide synthase; IkB, inhibitor kB; IKK, IkB kinase; IFN-{gamma}, interferon-{gamma}; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; LPS, lipopolysaccharide; NF-kB, nuclear factor-kB; NO, nitric oxide; NOS, nitric oxide synthase; PGE2, prostaglandin E2.

4 To whom correspondence should be addressed Email: jenkun{at}ntumc1.mc.ntu.edu.tw


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
B. Velmurugan, R. P. Singh, A. Tyagi, and R. Agarwal
Inhibition of Azoxymethane-Induced Colonic Aberrant Crypt Foci Formation by Silibinin in Male Fisher 344 Rats
Cancer Prevention Research, October 1, 2008; 1(5): 376 - 384.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. D. Gardner, G. L. Brower, T. G. Voloshenyuk, and J. S. Janicki
Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens
Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H198 - H204.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Nicholas, S. Batra, M. A. Vargo, O. H. Voss, M. A. Gavrilin, M. D. Wewers, D. C. Guttridge, E. Grotewold, and A. I. Doseff
Apigenin Blocks Lipopolysaccharide-Induced Lethality In Vivo and Proinflammatory Cytokines Expression by Inactivating NF-{kappa}B through the Suppression of p65 Phosphorylation
J. Immunol., November 15, 2007; 179(10): 7121 - 7127.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Horia and B. A. Watkins
Complementary actions of docosahexaenoic acid and genistein on COX-2, PGE2 and invasiveness in MDA-MB-231 breast cancer cells
Carcinogenesis, April 1, 2007; 28(4): 809 - 815.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Tong, R. T. Van Dross, A. Abu-Yousif, A. R. Morrison, and J. C. Pelling
Apigenin Prevents UVB-Induced Cyclooxygenase 2 Expression: Coupled mRNA Stabilization and Translational Inhibition
Mol. Cell. Biol., January 1, 2007; 27(1): 283 - 296.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. Swami, A. V. Krishnan, J. Moreno, R. B. Bhattacharyya, D. M. Peehl, and D. Feldman
Calcitriol and Genistein Actions to Inhibit the Prostaglandin Pathway: Potential Combination Therapy to Treat Prostate Cancer
J. Nutr., January 1, 2007; 137(1): 205S - 210S.
[Abstract] [Full Text] [PDF]


Home page
JPEN J Parenter Enteral NutrHome page
D. E. C. van Hoorn, R. J. Nijveldt, P. G. Boelens, Z. Hofman, P. A. M. van Leeuwen, and K. van Norren
Effects of Preoperative Flavonoid Supplementation on Different Organ Functions in Rats
JPEN J Parenter Enteral Nutr, July 1, 2006; 30(4): 302 - 308.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Vanamala, T. Leonardi, B. S. Patil, S. S. Taddeo, M. E. Murphy, L. M. Pike, R. S. Chapkin, J. R. Lupton, and N. D. Turner
Suppression of colon carcinogenesis by bioactive compounds in grapefruit
Carcinogenesis, June 1, 2006; 27(6): 1257 - 1265.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. Shukla and S. Gupta
Molecular targets for apigenin-induced cell cycle arrest and apoptosis in prostate cancer cell xenograft.
Mol. Cancer Ther., April 1, 2006; 5(4): 843 - 852.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. D. Gardner, G. L. Brower, and J. S. Janicki
Effects of dietary phytoestrogens on cardiac remodeling secondary to chronic volume overload in female rats
J Appl Physiol, October 1, 2005; 99(4): 1378 - 1383.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
P. C. Karlsson, U. Huss, A. Jenner, B. Halliwell, L. Bohlin, and J. J. Rafter
Human Fecal Water Inhibits COX-2 in Colonic HT-29 Cells: Role of Phenolic Compounds
J. Nutr., October 1, 2005; 135(10): 2343 - 2349.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Cai, M. Al-Fayez, R. G. Tunstall, S. Platton, P. Greaves, W. P. Steward, and A. J. Gescher
The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice
Mol. Cancer Ther., September 1, 2005; 4(9): 1287 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C.-C. Chen, M.-P. Chow, W.-C. Huang, Y.-C. Lin, and Y.-J. Chang
Flavonoids Inhibit Tumor Necrosis Factor-{alpha}-Induced Up-Regulation of Intercellular Adhesion Molecule-1 (ICAM-1) in Respiratory Epithelial Cells through Activator Protein-1 and Nuclear Factor-{kappa}B: Structure-Activity Relationships
Mol. Pharmacol., September 1, 2004; 66(3): 683 - 693.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. Svehlikova, S. Wang, J. Jakubikova, G. Williamson, R. Mithen, and Y. Bao
Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells
Carcinogenesis, September 1, 2004; 25(9): 1629 - 1637.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Shukla and S. Gupta
Suppression of Constitutive and Tumor Necrosis Factor {alpha}-Induced Nuclear Factor (NF)-{kappa}B Activation and Induction of Apoptosis by Apigenin in Human Prostate Carcinoma PC-3 Cells: Correlation with Down-Regulation of NF-{kappa}B-Responsive Genes
Clin. Cancer Res., May 1, 2004; 10(9): 3169 - 3178.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Zhang, A. Weber, B. Li, R. Lyons, P. R. Contag, A. F. Purchio, and D. B. West
An Inducible Nitric Oxide Synthase-Luciferase Reporter System for In Vivo Testing of Anti-inflammatory Compounds in Transgenic Mice
J. Immunol., June 15, 2003; 170(12): 6307 - 6319.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. N. Yadav, Z. Liu, and M. M. Rafi
A Diarylheptanoid from Lesser Galangal (Alpinia officinarum) Inhibits Proinflammatory Mediators via Inhibition of Mitogen-Activated Protein Kinase, p44/42, and Transcription Factor Nuclear Factor-{kappa}B
J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 925 - 931.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
A.-H. Lo, Y.-C. Liang, S.-Y. Lin-Shiau, C.-T. Ho, and J.-K. Lin
Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-{kappa}B in mouse macrophages
Carcinogenesis, June 1, 2002; 23(6): 983 - 991.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
H. Koo, P. L. Rosalen, J. A. Cury, Y. K. Park, and W. H. Bowen
Effects of Compounds Found in Propolis on Streptococcus mutans Growth and on Glucosyltransferase Activity
Antimicrob. Agents Chemother., May 1, 2002; 46(5): 1302 - 1309.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Romieu-Mourez, E. Landesman-Bollag, D. C. Seldin, A. M. Traish, F. Mercurio, and G. E. Sonenshein
Roles of IKK Kinases and Protein Kinase CK2 in Activation of Nuclear Factor-{{kappa}}B in Breast Cancer
Cancer Res., May 1, 2001; 61(9): 3810 - 3818.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. J. Weyant, A. M. Carothers, A. J. Dannenberg, and M. M. Bertagnolli
(+)-Catechin Inhibits Intestinal Tumor Formation and Suppresses Focal Adhesion Kinase Activation in the Min/+ Mouse
Cancer Res., January 1, 2001; 61(1): 118 - 125.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
T. Tanaka, H. Kohno, R. Shimada, S. Kagami, F. Yamaguchi, S. Kataoka, T. Ariga, A. Murakami, K. Koshimizu, and H. Ohigashi
Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats
Carcinogenesis, June 1, 2000; 21(6): 1183 - 1189.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.